Nutralife MaxiMan
Natural health product licensed in Canada
- Other names
- Purecure MaxiMan
- Licence holder
- EIG Canada
- NPN or DIN-HM
- 80053127
- Status
- Inactive licence
- Licence date
- 14 August 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-arginine Source : Monohydrochlorure de L-arginine | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Cellulose microcristalline, Colloidal silicon dioxide
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 19 years | 2 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help enhance physical capacity/performance. Helps to support peripheral circulation. L-Arginine is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053127
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.